Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

被引:25
|
作者
Simon, Tobias [1 ]
Becker, Ruediger [1 ]
Voss, Frederik [1 ]
Bikou, Olympia [1 ]
Hauck, Melanie [1 ]
Licka, Manuela [1 ]
Katus, Hugo A. [1 ]
Bauer, Alexander [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
nonischemic cardiomyopathy; risk stratification; non sustained ventricular tachycardias; NT-pro BNP; sudden cardiac death;
D O I
10.1007/s00392-007-0629-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with nonischemic cardiomyopathy (DCM) are at high risk for sudden cardiac death (SCD). However, the predictive value of prophylactic implantation of implantable cardioverter defibrillators (ICD) in this patient cohort is yet unclear. Methods and Results: Whether NT pro BNP levels and/or reproducible non sustained ventricular tachycardias (NSVTs) are predictive for SCD was prospectively tested in 30 patients with DCM and LVEF <= 40%. All patients received Holter-recordings (HR) on three consecutive days and baseline NT-pro BNP levels were determined. Patients were followed for occurrence of ventricular tachyarrhythmias or unexplained syncope. A great degree of variability was found regarding the occurrence of NSVTs (10% had NSVTs in two consecutive HR, 10% in three consecutive HR, 30% in one HR and 50% had no NSVTs). Patients with NSVTs in more than one HR had significantly higher NT-pro BNP levels (first quartile: 715 pg/ml, median 2,176 pg/ml, third quartile 5,755 pg/ml vs. first quartile 273 pg/ml, median 566 pg/ml, third quartile 1,350 pg/ml, P = 0.0388). During a mean follow-up of 21.6 +/- 1.2 months patients with an arrhythmic event had significantly higher NT-pro BNP levels than patients without event (first quartile: 1,002 pg/ml, median 4,075 pg/ml, third quartile 7,777 pg/ml vs. first quartile 173 pg/ml, median 267 pg/ml, third quartile 1,220 pg/ml, P = 0.0135). NT-pro BNP levels of 2,259 pg/ml were identified as optimal cut-off value for the prediction of arrhythmic events (P = 0.0313). In contrast reproducible NSVTs were not predictive for arrhythmic events (P = 0.0960). Conclusion: The present study demonstrates that in patients with DCM the value of reproducible NSVTs in predicting arrhythmic events is low. In contrast raised NT-pro BNP levels significantly correlated with occurrence of symptomatic ventricular arrhythmias. Larger prospective trials are required to confirm these results.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [31] B-type natriuretic peptide-guided therapy: a systematic review
    Balion, Cynthia
    McKelvie, Robert
    Don-Wauchope, Andrew C.
    Santaguida, Pasqualina L.
    Oremus, Mark
    Keshavarz, Homa
    Hill, Stephen A.
    Booth, Ronald A.
    Ali, Usman
    Brown, Judy A.
    Bustamam, Amy
    Sohel, Nazmul
    Raina, Parminder
    HEART FAILURE REVIEWS, 2014, 19 (04) : 553 - 564
  • [32] B-type natriuretic peptide-guided therapy: a systematic review
    Cynthia Balion
    Robert McKelvie
    Andrew C. Don-Wauchope
    Pasqualina L. Santaguida
    Mark Oremus
    Homa Keshavarz
    Stephen A. Hill
    Ronald A. Booth
    Usman Ali
    Judy A. Brown
    Amy Bustamam
    Nazmul Sohel
    Parminder Raina
    Heart Failure Reviews, 2014, 19 : 553 - 564
  • [33] What anesthesiologists should know about B-type natriuretic peptide
    Noveanu, M.
    Hartwiger, S.
    Mueller, C.
    MINERVA ANESTESIOLOGICA, 2009, 75 (12) : 698 - 702
  • [34] N-Terminal B-type Natriuretic Peptide in Heart Failure
    Richards, Arthur Mark
    HEART FAILURE CLINICS, 2018, 14 (01) : 27 - +
  • [35] Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension
    Lammers, Astrid E.
    Hislop, Alison A.
    Haworth, Sheila G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 135 (01) : 21 - 26
  • [36] No improvement in studies reporting the diagnostic accuracy of B-type natriuretic peptide
    Krzych, Lukasz J.
    Liszka, Lukasz
    MEDICAL SCIENCE MONITOR, 2009, 15 (05): : SR5 - SR14
  • [37] B-type Natriuretic Peptide circulating forms: Analytical and bioactivity issues
    Yandle, Tim G.
    Richards, A. Mark
    CLINICA CHIMICA ACTA, 2015, 448 : 195 - 205
  • [38] Could B-type Natriuretic Peptide (BNP) plasma concentration be useful to predict fluid in critically ill patients with acute circulatory failure?
    Muller, L.
    Louart, G.
    Teboul, J. -L.
    Mahamat, A.
    Polge, A.
    Bertinchant, J. -P.
    Ripart, J.
    de la Coussaye, J. -E.
    Lefrant, J. -Y.
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2009, 28 (06): : 531 - 536
  • [39] Effects of B-type natriuretic peptide on cardiovascular biomarkers in healthy volunteers
    Resl, M.
    Vila, G.
    Grimm, G.
    Heinisch, B.
    Riedl, M.
    Dieplinger, B.
    Mueller, T.
    Luger, A.
    Clodi, M.
    JOURNAL OF APPLIED PHYSIOLOGY, 2015, 118 (04) : 395 - 399
  • [40] Expression of B-type natriuretic peptide forms in ischemic human hearts
    Cortes, Raquel
    Rosello-Lleti, Esther
    Rivera, Miguel
    Martinez-Dolz, Luis
    Salvador, Antonio
    Sirera, Rafael
    Portoles, Manuel
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (02) : 199 - 204